BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer.
Shao ZM, Cai L, Wang S, Hu X, Shen K, Wang H, Li H, Feng J, Liu Q, Cheng J, Wu X, Wang X, Li H, Luo T, Liu J, Amin K, Slimane K, Qiao Y, Liu Y, Tong Z.
Shao ZM, et al. Among authors: cheng j.
Discov Oncol. 2024 Jun 21;15(1):237. doi: 10.1007/s12672-024-01027-8.
Discov Oncol. 2024.
PMID: 38904918